Andere talen Alligator Bioscience AB London S.E.

Aandelen

0RK9

SE0000767188

Beurs gesloten - London S.E. Andere beurzen 16:52:01 17-11-2021			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,508 ^SEK	-66,28%		+123,96%	+303,28%

23/05	Alligator Bioscience presenteert positieve fase 2-gegevens over mitazalimab bij alvleesklierkanker op de jaarlijkse ASCO-bijeenkomst in 2024	CI
21/05	US FDA geeft goedkeuring voor onderzoek naar een nieuw geneesmiddel voor Alligator Bioscience's proef met maagkankerbehandeling in een laat stadium	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting	23/05
US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial	21/05
Alligator Bioscience Announces Initiation of an Investigator-Initiated Phase 1 Clinical Study of Mitazalimab in Local Advanced Pancreatic Cancer	14/05
Transcript : Alligator Bioscience AB, Q1 2024 Earnings Call, May 06, 2024	06/05
Alligator Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
Alligator Bioscience and Orion Corporation Announces Exercise of Development Option Under 2021 Research Collaboration and License Agreement	26/04
Alligator Bioscience AB Announces Graham Dixon and Veronica Wallin Not Proposed for Re-Election on Board	05/04
Alligator Bioscience Announces Publication of a Scientific Article Featuring Its Novel Bispecific Antibody Format RUBY® in the Peer-Reviewed Journal mAbs	26/03
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07/03
Transcript : Alligator Bioscience AB, 2023 Earnings Call, Feb 09, 2024	09/02
Correction: Alligator Bioscience Seeks SEK151 Million Capital Raising, Enters SEK59 Million Bridge Loan	09/02
Alligator Bioscience Seeks SEK151 Capital Raising, Enters SEK59 Million Bridge Loan	09/02
Alligator Bioscience to Trim Workforce Amid Restructuring Program	08/02
Alligator Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	08/02
Alligator Bioscience Plans to Adjust Size of Organization with Reduction of Approximately 20% to 25% of Current Workforce	08/02
Transcript : Alligator Bioscience AB - Special Call	29/01
Alligator Bioscience Announces Positive Top-Line Results from the Optimize-1 Phase 2 Study of the Company's Lead Asset Mitazalimab in 1st Line Metastatic Pancreatic Cancer	29/01
Alligator Bioscience Secures US Patent for Cancer Treatment Antibody	16/01
Transcript : Alligator Bioscience AB - Analyst/Investor Day	01/12
Alligator Bioscience AB Appoints Bertil Brinck as Chairman of the Nomination Committee	06/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Alligator Bioscience AB London S.E.

Aandelen

0RK9

SE0000767188

Andere talen

Filters